Physical rehabilitation and symptom management still remain the mainstay of treatment for stroke, as clot removal or ...
New U.S. intellectual property protections expand use of Minovia’s leading technology in mitochondrial-based therapies for primary mitochondrial and severe renal diseasesHAIFA, Israel, Jan. 13, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results